benign thyroid conditions E04.0
Conditions
Interventions
Group 1: 0,5 mcg Calcitriol p.o., b.i.d. for three days prior to surgery
Group 2: none
Sponsors
Sana Klinikum Offenbach
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: Written Informed Consent Benign Thyroid Condition Total Thyroidectomy
Exclusion criteria
Exclusion criteria: Age 85 of Years, Noncompliance with relevant study procedures, visit schedule and follow up , non-eligibility for and/or no reasonable access to outpatient care, pregnancy, present musculoscelettal disease or co-medication known to affect calcium metabolism (Vitamine D, Hydrochlorothiazides, estrogenes, glycosides), malignancy of the thyroid gland, competing therapies or procedures and or simultaneous participation in other clinical trials and withdrawal of informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint is defined as the number of participants with a postoperative serumcalcium of < 2,1 mmol/l at any of the in hospital days following surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| Time (Number of days) to discharge; Health-economic endpoints (hypocalcaemia questionnaire, SF 36®) | — |
Countries
Germany
Contacts
Public ContactStefanie Wolak
Klinikum Hanau GmbH
Outcome results
None listed